UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
2 professors in legal battle over textbook authorship
Ahn Hee-chang, a plastic surgery professor at Hanyang University Hospital, ...
by Song Soo-youn
|
2018-03-22 14:56
라인
Yuyu to start clinical trials on dry eye treatment
Yuyu Pharmaceuticals said Thursday that it has received approval from the M...
by Lee Han-soo
|
2018-03-22 14:34
라인
Daewoong to promote AstraZeneca’s diabetes treatment
Daewoong Pharmaceutical and AstraZeneca Korea have signed a co-promotion pa...
by Lee Han-soo
|
2018-03-22 11:25
라인
Daiichi Sankyo Korea to co-market Kuhnil’s dyslipidemia treatment
Daiichi Sankyo Korea said Thursday that it has signed a strategic partnersh...
by Lee Han-soo
|
2018-03-22 11:25
라인
European urology group praises Gemvax & KAEL’s research paper
Gemvax & KAEL said Wednesday that the European Association of Urology (EAU)...
by Lee Han-soo
|
2018-03-22 11:24
라인
Roche’s Tecentriq gets reimbursement as 2nd line treatment for 2 cancers
Roche Korea (CEO: Matt Sause) said Wednesday that the country’s first anti ...
by Marian Chu
|
2018-03-21 18:27
라인
Why is biopharmaceutical outlook rosy, despite bubble concern?
Celltrion Inc. and SillaJen are two representative pharmaceutical companies...
by Park Gi-taek
|
2018-03-21 16:04
라인
JW Pharma gets orphan drug status for Roche’s hemophilia treatment
JW Pharmaceutical said Wednesday that the Ministry of Food and Drug Safety ...
by Lee Han-soo
|
2018-03-21 15:47
라인
Daewoong promotes botulinum toxin Nabota in Dubai
Daewoong Pharmaceutical has begun pushing international marketing activitie...
by So Jae-hyeon
|
2018-03-21 15:47
라인
Genexine gets FDA nod for trials on immunotherapeutic agent
Genexine said Tuesday that it has received approval to go ahead with the ph...
by Lee Han-soo
|
2018-03-21 11:40
라인
4 drugmakers’ profits turn to losses
Among KOSDAQ-listed pharmaceutical companies, four firms’ operating profits...
by Nam Doo-hyun
|
2018-03-21 11:38
라인
Access Bio Korea dedicates local factory
Access Bio Korea, a subsidiary of Access Bio, dedicated its first local fac...
by Lee Han-soo
|
2018-03-21 10:35
라인
Merck Korea says study confirms safety, efficacy of heart drug in Asian patients
Merck Biopharma Korea said that its coronary heart disease drug Concor (bis...
by Marian Chu
|
2018-03-20 19:42
라인
Seoul to punish drugmakers for offering rebates via outsourced firms
The government has toughened up regulations on outsourced pharmaceutical co...
by So Jae-hyeon
|
2018-03-20 16:30
라인
Genexine’s clinical trial on persistent growth hormone running smoothly
Genexine and Handok have announced the intermediate results of phase 2 clin...
by Lee Han-soo
|
2018-03-20 16:19
라인
Researchers unveil indicator that can predict strokes
Researchers at Seoul National University Hospital (SNUH) and Korea Universi...
by Lee Han-soo
|
2018-03-20 14:47
라인
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion
Foreign investors net purchased shares of SillaJen and Samsung BioLogics, a...
by Nam Doo-hyun
|
2018-03-20 12:01
라인
What will be 1st approved stem cell treatment this year?
Domestic companies are rolling out developments on stem cell treatments, le...
by So Jae-hyeon
|
2018-03-20 11:34
라인
World’s top painkiller Advil underperforms in Korea
Advil, the world’s best-selling pain reliever, is not performing well in Ko...
by So Jae-hyeon
|
2018-03-20 11:16
라인
Yonsei University Health System, Curexo to jointly develop surgical robot
Medical staff from Yonsei University Health System (YUHS) and Korean roboti...
by Marian Chu
|
2018-03-19 17:36
-
이전
231
232
233
234
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top